Evaluation of a Clinical Pharmacist-led Discharge Education Service in Patients With Acute Coronary Syndrome: A Randomized Controlled Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 177
- 试验地点
- 1
- 主要终点
- 30 days hospital re-admission for cardiac reasons
研究概览
简要总结
To evaluate the impact of clinical pharmacist-led discharge education service in patients with acute coronary syndrome.
详细描述
This prospective, randomized controlled study was conducted in patients with acute coronary syndrome in an cardiology service of tertiary training and research hospital. The clinical pharmacist, within the scope of the discharge education services, provided medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally [by using Teach back method especially for patients with low health literacy]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model). The control group received standard care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients admitted to the cardiology department due to acute coronary syndrome
- •Older than 18 years old
排除标准
- •Patients who transferred to another ward
- •Patients with active malignancy
- •Patients with alzheimer and/or dementia diagnosis
- •Patient with >%80 visual loss or deaf muteness reported at medical record
结局指标
主要结局
30 days hospital re-admission for cardiac reasons
时间窗: 30 days
Proportion of patients readmitted to hospital for cardiac cause at 1 month
次要结局
- Hospital re-admission for cardiac reasons(3 months, 6 months, and 12 months)
- Emergency service visits(1 month, 3 months, 6 months, and 12 months)
- Hospital re-admission for any reasons(1 month, 3 months, 6 months, and 12 months)
- Death for cardiac reason(1 month, 3 months, 6 months, and 12 months)
- Medication Adherence(1 month, 3 months, 6 months, and 12 months)
- Major Adverse Cardiovascular Event(1 month, 3 months, 6 months, and 12 months)
- Death for any reason(1 month, 3 months, 6 months, and 12 months)
- Quality of Life Measurement(1 month, 3 months, 6 months, and 12 months)
- Achieved Target Low-density Lipoprotein Value(6 months, 12 months)
研究者
Betul Okuyan
Assoc.Prof.
Marmara University